271 related articles for article (PubMed ID: 22000579)
41. Proton FLASH Radiotherapy Ameliorates Radiation-induced Salivary Gland Dysfunction and Oral Mucositis and Increases Survival in a Mouse Model of Head and Neck Cancer.
Chowdhury P; Velalopoulou A; Verginadis II; Morcos G; Loo PE; Kim MM; Motlagh SAO; Shoniyozov K; Diffenderfer ES; Ocampo EA; Putt M; Assenmacher CA; Radaelli E; Lu J; Qin L; Liu H; Leli NM; Girdhani S; Denef N; Vander Stappen F; Cengel KA; Busch TM; Metz JM; Dong L; Lin A; Koumenis C
Mol Cancer Ther; 2024 Jun; 23(6):877-889. PubMed ID: 38593239
[TBL] [Abstract][Full Text] [Related]
42. Harnessing the power of bacteria to protect the gut.
Abreu MT
N Engl J Med; 2008 Aug; 359(7):756-9. PubMed ID: 18703481
[No Abstract] [Full Text] [Related]
43. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.
Melin N; Sánchez-Taltavull D; Fahrner R; Keogh A; Dosch M; Büchi I; Zimmer Y; Medová M; Beldi G; Aebersold DM; Candinas D; Stroka D
Cell Death Dis; 2021 Apr; 12(4):366. PubMed ID: 33824326
[TBL] [Abstract][Full Text] [Related]
44. NLRC4 Mutation in flagellin-derived peptide CBLB502 ligand-binding domain reduces the inflammatory response but not radioprotective activity.
Lai L; Yang G; Yao X; Wang L; Zhan Y; Yu M; Yin R; Li C; Yang X; Ge C
J Radiat Res; 2019 Nov; 60(6):780-785. PubMed ID: 31599956
[TBL] [Abstract][Full Text] [Related]
45. Acute Oral Mucositis During Hypo-Fractionated Radiation in Squamous Cell Carcinoma of Oral Cavity.
Hammad AM; Abrar S; Tahseen R; Qureshi BM; Hafiz A; Abbasi AN
J Coll Physicians Surg Pak; 2023 Dec; 33(12):1460-1462. PubMed ID: 38062608
[TBL] [Abstract][Full Text] [Related]
46. [Clinical evaluation of sodium alginate on oral mucositis associated with radiotherapy].
Oshitani T; Okada K; Kushima T; Suematsu T; Obayashi K; Hirata Y; Takada Y; Ishida T; Yoshida M; Narabayashi I
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1129-37. PubMed ID: 2398298
[TBL] [Abstract][Full Text] [Related]
47. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.
Hong JP; Lee SW; Song SY; Ahn SD; Shin SS; Choi EK; Kim JH
Eur J Cancer Care (Engl); 2009 Nov; 18(6):636-41. PubMed ID: 19456848
[TBL] [Abstract][Full Text] [Related]
48. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
Russo G; Haddad R; Posner M; Machtay M
Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
[TBL] [Abstract][Full Text] [Related]
49. Radioprotective effect of newly synthesized toll-like receptor 5 agonist, KMRC011, in mice exposed to total-body irradiation.
Kim JY; Park JH; Seo SM; Park JI; Jeon HY; Lee HK; Yoo RJ; Lee YJ; Woo SK; Lee WJ; Choi CM; Choi YK
J Radiat Res; 2019 Jul; 60(4):432-441. PubMed ID: 31165150
[TBL] [Abstract][Full Text] [Related]
50. A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model.
Mangoni M; Sottili M; Gerini C; Desideri I; Bastida C; Pallotta S; Castiglione F; Bonomo P; Meattini I; Greto D; Olmetto E; Terziani F; Becherini C; Delli Paoli C; Trombetta L; Loi M; Biti G; Livi L
Oral Oncol; 2017 Jan; 64():52-58. PubMed ID: 28024724
[TBL] [Abstract][Full Text] [Related]
51. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer.
Bensadoun RJ; Franquin JC; Ciais G; Darcourt V; Schubert MM; Viot M; Dejou J; Tardieu C; Benezery K; Nguyen TD; Laudoyer Y; Dassonville O; Poissonnet G; Vallicioni J; Thyss A; Hamdi M; Chauvel P; Demard F
Support Care Cancer; 1999 Jul; 7(4):244-52. PubMed ID: 10423050
[TBL] [Abstract][Full Text] [Related]
52. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
[TBL] [Abstract][Full Text] [Related]
53. Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis-Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation.
Gruber S; Arnold M; Cini N; Gernedl V; Hetzendorfer S; Kowald LM; Kuess P; Mayer J; Morava S; Pfaffinger S; Rohorzka A; Dörr W
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882770
[TBL] [Abstract][Full Text] [Related]
54. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
Vacha P; Marx M; Engel A; Richter E; Feyerabend T
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
[TBL] [Abstract][Full Text] [Related]
55. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
Mett V; Komarova EA; Greene K; Bespalov I; Brackett C; Gillard B; Gleiberman AS; Toshkov IA; Aygün-Sunar S; Johnson C; Karasik E; Bapardekar-Nair M; Kurnasov OV; Osterman AL; Stanhope-Baker PS; Morrison C; Moser MT; Foster BA; Gudkov AV
Oncogene; 2018 Jan; 37(4):439-449. PubMed ID: 28967901
[TBL] [Abstract][Full Text] [Related]
56. The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates.
Krivokrysenko VI; Toshkov IA; Gleiberman AS; Krasnov P; Shyshynova I; Bespalov I; Maitra RK; Narizhneva NV; Singh VK; Whitnall MH; Purmal AA; Shakhov AN; Gudkov AV; Feinstein E
PLoS One; 2015; 10(9):e0135388. PubMed ID: 26367124
[TBL] [Abstract][Full Text] [Related]
57. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
[TBL] [Abstract][Full Text] [Related]
58. Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapy.
Narayan S; Lehmann J; Coleman MA; Vaughan A; Yang CC; Enepekides D; Farwell G; Purdy JA; Laredo G; Nolan K; Pearson FS; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):756-62. PubMed ID: 18417299
[TBL] [Abstract][Full Text] [Related]
59. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
60. Radiotherapy mucositis in head and neck cancer: prevention by low-energy surface laser.
Bourbonne V; Otz J; Bensadoun RJ; Dissaux G; Lucia F; Leclere JC; Pradier O; Schick U
BMJ Support Palliat Care; 2022 Dec; 12(e6):e838-e845. PubMed ID: 31527154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
